Abstract
Introduction The concept of the commercial determinants of health (CDH) is used to study the actions (and associated structures) of commercial entities that influence population health and health equity. The aim of this study was to develop a typology that describes the diverse set of activities through which corporations influence population health and health equity across industries.
Methods We conducted a scoping review of articles using CDH terms (n=116) that discuss corporate activities that can influence population health and health equity across 16 industries. We used the qualitative constant comparison method to build a typology called the Corporate Influences on Population Health (HEALTH-CORP) typology.
Results The HEALTH-CORP typology identifies 70 corporate activities that can influence health across industries and categorizes them into seven domains of corporate influence (e.g., political practices, employment practices). We present a model that situates these domains based on their proximity to health outcomes and identify five population groups (e.g., workers, local communities) to consider when evaluating corporate health impacts.
Discussion The HEALTH-CORP typology facilitates an understanding of the diverse set of corporate activities that can influence population health and the population groups affected by these activities. We discuss the utility of these contributions in terms of identifying interventions to address the CDH and advancing efforts to measure and monitor the CDH. We also leverage our findings to identify key gaps in CDH literature and suggest avenues for future research.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Raquel Burgess was supported by a Doctoral Foreign Study Award provided by the Canadian Institutes of Health Research at the time this research was conducted. Funding was provided by the Yale School of Public Health and the Yale Graduate Student Assembly to present this work at the American Public Health Association Annual Meeting in 2022.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The data for this study are published academic articles which are available from the respective publishers (see Supplementary Material, Appendix 2 for the characteristics of included articles). In addition, we uploaded the following files to Open Science Framework (DOI 10.17605/OSF.IO/TG9S7) to support data availability: 1) a .csv file containing a list of the articles that underwent title and abstract screening in our study and the respective screening decisions that were assigned, and 2) .ris files containing the citations to the respective articles and the assigned screening decisions, which can be uploaded into a reference manager. Interested parties can contact the corresponding author for additional information.
List of abbreviations
- CDH
- Commercial determinants of health SDH: Social determinants of health
- HEALTH-CORP
- Corporate Influences on Population Health PRISMA-ScR: PRISMA Extension for Scoping Reviews
- CSR
- Corporate Social Responsibility
- CDC
- Centers for Disease Control and Prevention HICs: High-income countries
- LMICs
- Low- and middle-income countries F&B: Food and beverage